Israel China Biotechnology (ICB) Ltd (ICB) — Defensive Interval Ratio
Israel China Biotechnology (ICB) Ltd (ICB) has a Defensive Interval Ratio of 13 days as of June 2021. Defensive assets of ILA116.00K (cash ILA-, short-term investments ILA-, receivables ILA116.00K) cover 13 days of daily cash needs of ILA8.80K/day. See ICB net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Israel China Biotechnology (ICB) Ltd Defensive Interval Ratio (2015–2020)
This chart shows how Israel China Biotechnology (ICB) Ltd's Defensive Interval Ratio has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the ratio stands at 13 days, meaning defensive assets of ILA116.00K can fund 13 days of operations without new revenue. See Israel China Biotechnology (ICB) Ltd (ICB) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below presents the year-by-year Defensive Interval Ratio for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ICB stock market capitalisation.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2020 | 3 days | ILA47.00K | ILA18.06K/day | ILA- | ILA- | ▲ +1 days |
| 2019 | 2 days | ILA39.00K | ILA20.16K/day | ILA- | ILA- | ▲ +0 days |
| 2018 | 2 days | ILA6.00K | ILA3.30K/day | ILA- | ILA- | ▼ -7 days |
| 2017 | 9 days | ILA26.00K | ILA2.87K/day | ILA- | ILA- | ▼ -109 days |
| 2016 | 118 days | ILA111.00K | ILA942.47/day | ILA- | ILA- | ▲ +84 days |
| 2015 | 33 days | ILA50.00K | ILA1.50K/day | ILA- | ILA- | — |